Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Ornithine Transcarbamylase (OTC) Deficiency Treatment Market is Segmented by Treatment Type (Glycerol Phenylbutyrate, Sodium Phenylbutyrate, Sodium Phenylacetate and Sodium Benzoate, and Other Treatment Types), Route of Administration (Oral and Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Other Distribution Channels), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The Report Offers Market Sizes and Forecasts in Terms of Value (USD) for all the Above Segments.

Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Ornithine Transcarbamylase Deficiency Treatment Industry Overview

The ornithine transcarbamylase (OTC) deficiency treatment market is consolidated due to key players capturing the bulk of market share globally and regionally. The competitive landscape includes an analysis of a few international and local companies with substantial market shares. Some key players include Amgen Inc. (Horizon Therapeutics PLC), Bausch Health Companies Inc., Ultragenyx Pharmaceutical Inc., Arcturus Therapeutics Inc., Zevra Therapeutics (Acer Therapeutics), iECURE, Danone Group (Nutricia), Abbott, Reckitt Benckiser, Nestle, Moderna Inc., Duchesnay Pharmaceutical Group-DPG (Medunik USA), and Eurocept Pharmaceuticals Holding (Lucane Pharma).

Ornithine Transcarbamylase Deficiency Treatment Market Leaders

  1. Amgen Inc. (Horizon Therapeutics plc)

  2. Bausch Health Companies Inc.

  3. Ultragenyx Pharmaceutical Inc.

  4. Arcturus Therapeutics, Inc.

  5. Zevra Therapeutics (Acer Therapeutics)

  6. *Disclaimer: Major Players sorted in no particular order
Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Concentration

Ornithine-Transcarbamylase (OTC) Deficiency Treatment Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?